All Sauce from Weekly Sauce:

TUESDAY, June 8, 2021 (American Heart Association News) — Black women are most likely to develop a severe form of high blood pressure during pregnancy called preeclampsia, a new study shows. But Asian and Pacific Islander women may have the highest risk for developing cardiovascular complications from the condition. The study, published Tuesday in the…  read on >  read on >

Jay-Fay Fraser was in the back seat of her father’s sedan, heading home from feeding the homeless on Thanksgiving 2016, when another car rear-ended them on the highway. The driver’s seat collapsed backward from the sudden force of the rear impact, slamming into Jay-Fay’s head, her mother, Michelle Fraser, recounted. “She lurched forward, the seat…  read on >  read on >

Fewer temptations at checkout? People may spend more money when they buy their groceries online, but they also tend to buy fewer unhealthy, “impulse-sensitive” foods like candy and cookies, new research shows. For the study, the researchers looked at the shopping habits of 137 primary household shoppers in Maine to compare their in-store and online…  read on >  read on >

Advocates of plant-based diets suggest they can reduce the risk of chronic illnesses such as heart disease and help the environment. Now, new research suggests they may provide another health benefit: lowering COVID-19 severity. A plant-based diet was associated with 73% lower odds of moderate to severe COVID-19 infection in the study. A pescatarian diet,…  read on >  read on >

New research suggests that many people who’ve undergone an organ transplant do not get an immune response from COVID-19 vaccines that’s strong enough to ward off a “breakthrough” infection. In a new review of 14 such cases, these breakthrough COVID-19 infections occurred in 10 recipients of new kidneys, two liver recipients, one lung recipient and…  read on >  read on >

The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer’s disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science. Aduhelm (aducanumab) treats Alzheimer’s by clearing out amyloid beta, a sticky protein known to form plaques in the brains of early-stage…  read on >  read on >